ArticleBMJ case reports2015
Use of the Impella 2.5 left ventricular assist device in a patient with cardiogenic shock secondary to takotsubo cardiomyopathy.
Article in BMJ case reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 32 citations in OpenAlex.
- Clinical characteristics and outcomes of patients with takotsubo syndrome versus spontaneous coronary artery dissection.Cardiology journal · 2023Trial
- Mechanical circulatory support for cardiogenic shock in takotsubo syndrome.Clinical research in cardiology : official journal of the German Cardiac Society · 2026Article
- Mechanical Circulatory Support Strategies in Takotsubo Syndrome with Cardiogenic Shock: A Systematic Review.Journal of clinical medicine · 2024Review
- Recurrent Stress-Induced Cardiomyopathy With Cardiogenic Shock Requiring Impella Left Ventricular Assist Device.Cureus · 2021Article
- Cardiovascular Imaging in Stress Cardiomyopathy (Takotsubo Syndrome).Frontiers in cardiovascular medicine · 2021Review
- [Circulatory support with venoarterial ECMO in a patient with biventricular Takotsubo cardiomyopathy].Archivos de cardiologia de Mexico · 2020Article
- A case of Takotsubo cardiomyopathy with cardiogenic shock after influenza infection successfully recovered by IMPELLA support.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2019Article
- An Emerging Cardiovascular Disease: Takotsubo Syndrome.BioMed research international · 2019Review
- Stress Cardiomyopathy Diagnosis and Treatment: JACC State-of-the-Art Review.Journal of the American College of Cardiology · 2018Review
- Acute pancreatitis-induced takotsubo cardiomyopathy and cardiogenic shock treated with a percutaneous left ventricular assist device.BMJ case reports · 2018Article
- Mechanical interventricular dependency supports hemodynamics in tako-tsubo cardiomyopathy.Journal of thoracic disease · 2018Article
- Mechanical circulatory support for refractory cardiogenic shock in Takotsubo syndrome: a case report and review of the literature.European heart journal. Case reports · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report a case of cardiogenic shock, believed to be secondary to stress-induced cardiomyopathy, managed by an Impella 2.5 assist device. Apical ballooning pattern was evident on left ventriculogram with no significant coronary artery disease on coronary angiography. Cardiogenic shock was initially managed medically with inotropes and vasopressors, but because the patient was clinically deteriorating, an Impella 2.5 left ventricular assist device was implanted. Remarkable recovery occurred within 48 h of implantation with significant increase in ejection fraction and only minimal residual apical hypokinesis observed on repeat ventriculogram.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.